From Screening to Solutions in Gestational Diabetes Diagnostics
- This event has passed.
November 20, 2025 @ 1:00 pm - 1:45 pm EST
Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Diagnostic tests and procedures offer opportunities to detect diseases earlier, guide intervention choices, and monitor and evaluate treatment effectiveness. Some diagnostic tests are invasive, such as a biopsy or endoscopy, whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.
Screening and diagnostic testing can help improve health outcomes and contribute toward reducing health disparities among women. Research seeking to expand the development and availability of diagnostic tools for conditions that exclusively, differently, or disproportionately affect women is invaluable in furthering women’s health across sectors.
SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events discuss how to improve health outcomes for diseases and conditions that disproportionately or differently affect women, with special a focus on maternal health.
The 2025 SWHR Value of Diagnostics within Women’s Health series includes:
- Applying Pressure to Diagnose Preeclampsia Better and Earlier (September 29, 2025)
- From Screening to Solutions in Gestational Diabetes Diagnostics (November 20, 2025)
This is an SWHR Event.
Goals
- Describe the impact of gestational diabetes on women’s maternal and long-term health outcomes
- Provide an overview of current practices and emerging innovations for screening and diagnosing gestational diabetes
- Discuss future considerations for improving patient access and prenatal care integration of diagnostic tools and techniques
Are you interested in seeing more of this type of educational programming on women’s health from SWHR?
Panelist
Maisa Feghali, MD, MS
Maisa Feghali, MD, MS
Dr. Feghali is an Associate Professor in the Department of Obstetrics and Gynecology and the division of Maternal Fetal Medicine. She leads the diabetes in pregnancy program at Magee Womens Hospital of UPMC. Her research has examined predictors of treatment response and neonatal adverse outcomes in women with diabetes in pregnancy. Her current work focuses on the variation in pathophysiology of diabetes in pregnancy and the potential role of individualized therapy.
The event is moderated by Syreen Goulmamine, MPH, CHES®, Science Programs Manager at the Society for Women’s Health Research.
Sponsor
Support for this educational program has been provided by Roche Diagnostics. SWHR maintains independence and editorial control over program development, content, and work products.
